BoNT/A also did not affect tumour growth when given to mice in which TRPV1+ nociceptor neurons were genetically ablated (Extended Data Fig. 7o), which suggests that its anti-tumour effectiveness depends on the presence of tumour-innervating nociceptor neurons. The gene discussed is TRPV1; the disease is neoplasm.